ARCHIVES

Trials Approved by NCI CTEP For the Month of April

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Interview with FDA’s Richard Pazdur

October 30, 2009

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

January 22, 1982

Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms

December 15, 1978

Advances Found In Treatment Of Aerodigestive Cancers

May 25, 2001